Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome.
暂无分享,去创建一个
Marinus J Eijkemans | M. Eijkemans | M. van Wely | B. Fauser | J. Laven | F. van der Veen | Joop S E Laven | Fulco van der Veen | Madelon van Wely | Bart C J M Fauser
[1] B. Fauser,et al. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. , 1997, The Journal of clinical endocrinology and metabolism.
[2] S. Christin‐Maitre,et al. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. , 2003, Human reproduction.
[3] E. Diamanti-Kandarakis,et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. , 1999, The Journal of clinical endocrinology and metabolism.
[4] J. L. San Millán,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain* , 1999 .
[5] T. Key,et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. , 1998, The Journal of clinical endocrinology and metabolism.
[6] R. Casamitjana,et al. Recombinant Human Follicle-Stimulating Hormone for Ovulation Induction in Polycystic Ovary Syndrome: A Prospective, Randomized Trial Of Two Starting Doses in a Chronic Low-Dose Step-up Protocol , 2000, Journal of Assisted Reproduction and Genetics.
[7] R. Homburg,et al. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. , 1999, Human reproduction update.
[8] P. Devroey,et al. Multiple birth resulting from ovarian stimulation for subfertility treatment , 2005, The Lancet.
[9] B. Fauser,et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.
[10] B. Fauser,et al. Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients. , 1995, Human reproduction.
[11] James B. Brown,et al. Pituitary Control of Ovarian Function — Concepts Derived from Gonadotrophin Therapy , 1978, The Australian & New Zealand journal of obstetrics & gynaecology.
[12] J. Habbema,et al. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. , 1998, The Journal of clinical endocrinology and metabolism.
[13] R. Homburg. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. , 2004, Best practice & research. Clinical obstetrics & gynaecology.
[14] Marinus J C Eijkemans,et al. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. , 2002, Fertility and sterility.
[15] S. Franks,et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. , 1996, The Journal of clinical endocrinology and metabolism.
[16] P. J. Rowe,et al. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple , 1993 .
[17] M. Eijkemans,et al. Patient-tailored conventional ovulation induction algorithms in anovulatory infertility , 2005, Trends in Endocrinology & Metabolism.
[18] L. Giudice,et al. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. , 2002, Fertility and sterility.
[19] J. Habbema,et al. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). , 2003, Human reproduction.
[20] M. Aboulghar,et al. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. , 2003, Human reproduction update.
[21] Jesse A. Berlin,et al. Assessing the Generalizability of Prognostic Information , 1999 .
[22] Serge Rozenberg,et al. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. , 2002, Human reproduction update.
[23] P. Bossuyt,et al. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial , 2004, BMJ : British Medical Journal.
[24] B. Fauser,et al. Manipulation of human ovarian function: physiological concepts and clinical consequences. , 1997, Endocrine reviews.
[25] M. Hull. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. , 1987, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[26] W. Hop,et al. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. , 1995, Fertility and sterility.
[27] P. Claman. Men at risk: occupation and male infertility. , 2004, Fertility and sterility.
[28] F. Veen,et al. Urofollitropin and Ovulation Induction , 2005, Treatments in endocrinology.